Inclusion of Nitrofurantoin into the Realm of Cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing.

Structural modifications of the antibacterial drug nitrofurantoin were envisioned, employing drug repurposing and biology-oriented drug synthesis, to serve as possible anticancer agents. Eleven compounds showed superior safety in non-cancerous human cells. Their antitumor efficacy was assessed on colorectal, breast, cervical, and liver cancer cells. Three compounds induced oxidative DNA damage in cancer cells with subsequent cellular apoptosis. They also upregulated the expression of Bax while downregulated that of Bcl-2 along with activating caspase 3/7. The DNA damage induced by these compounds, demonstrated by pATM nuclear shuttling, was comparable in both MCF7 and MDA-MB-231 (p53 mutant) cell lines. Mechanistic studies confirmed the dependence of these compounds on p53-mediated pathways as they suppressed the p53-MDM2 interaction. Indeed, exposure of radiosensitive prostatic cancer cells to low non-cytotoxic concentrations of compound 1 enhanced the cytotoxic response to radiation indicating a possible synergistic effect. In vivo antitumor activity was verified in an MCF7-xenograft animal model.

[1]  H. Gali-Muhtasib,et al.  Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models , 2022, Cancers.

[2]  H. Sonaye,et al.  Drug repurposing: Iron in the fire for older drugs. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  F. Zouein,et al.  Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis. , 2021, Bioorganic chemistry.

[4]  A. El-Yazbi,et al.  Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones , 2021, Journal of enzyme inhibition and medicinal chemistry.

[5]  A. Lavecchia,et al.  Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy. , 2020, Bioorganic chemistry.

[6]  C. Supuran,et al.  Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases. , 2020, European journal of medicinal chemistry.

[7]  A. Majouga,et al.  Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction , 2020, Molecules.

[8]  Vivek Gupta,et al.  Drug repurposing: a promising tool to accelerate the drug discovery process. , 2019, Drug discovery today.

[9]  M. Bartolini,et al.  Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase. , 2019, European journal of medicinal chemistry.

[10]  Suganya Mani,et al.  Antineoplastic Effect of PAC Capped Silver Nanoparticles Promote Apoptosis in HT-29 Human Colon Cancer Cells , 2019, Journal of Cluster Science.

[11]  Tamer M. Ibrahim,et al.  Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones. , 2019, European journal of medicinal chemistry.

[12]  A. L. Fallacara,et al.  One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors. , 2018, Future medicinal chemistry.

[13]  Amira F. El-Yazbi,et al.  Probing DNA damage induced by common antiviral agents using multiple analytical techniques , 2018, Journal of pharmaceutical and biomedical analysis.

[14]  A. Bekhit,et al.  Anti-leishmanial click modifiable thiosemicarbazones: Design, synthesis, biological evaluation and in silico studies. , 2018, European journal of medicinal chemistry.

[15]  A. Lavecchia,et al.  Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes , 2017, Scientific Reports.

[16]  L. Sleire,et al.  Drug repurposing in cancer. , 2017, Pharmacological research.

[17]  Jae Hong Park,et al.  In vitro exposure of simulated meat-cooking fumes to assess adverse biological effects , 2017, Scientific Reports.

[18]  Fatma H. El-Rashidy,et al.  In Vitro Collapsing Colon Cancer Cells by Selectivity of Disulfiram-Loaded Charge Switchable Nanoparticles Against Cancer Stem Cells. , 2017, Recent Patents on Anti-Cancer Drug Discovery.

[19]  Stephen N. Jones,et al.  Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis. , 2016, Translational cancer research.

[20]  T. Silva,et al.  N-pentyl-nitrofurantoin induces apoptosis in HL-60 leukemia cell line by upregulating BAX and downregulating BCL-xL gene expression , 2016, Pharmacological reports : PR.

[21]  T. Luo,et al.  Pravastatin inhibits tumor growth through elevating the levels of apolipoprotein A1 , 2016 .

[22]  Yuquan Wei,et al.  Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma , 2016, Scientific Reports.

[23]  Pan Pantziarka,et al.  Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent , 2015, Ecancermedicalscience.

[24]  Amira F. El-Yazbi,et al.  Detecting UV-induced Nucleic Acid Damage , 2014 .

[25]  D. Krysan,et al.  Repurposing the Antihistamine Terfenadine for Antimicrobial Activity against Staphylococcus aureus , 2014, Journal of medicinal chemistry.

[26]  U. Moll,et al.  Mitochondrial death functions of p53 , 2014, Molecular & cellular oncology.

[27]  Zhiyun Cao,et al.  Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing mice , 2014, Oncology letters.

[28]  M. García-Rodríguez,et al.  Antigenotoxic and Apoptotic Activity of Green Tea Polyphenol Extracts on Hexavalent Chromium-Induced DNA Damage in Peripheral Blood of CD-1 Mice: Analysis with Differential Acridine Orange/Ethidium Bromide Staining , 2013, Oxidative medicine and cellular longevity.

[29]  V. Pant,et al.  The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity , 2013, Genes & development.

[30]  Jianzhong Chen,et al.  Molecular Dynamic Simulation Insights into the Normal State and Restoration of p53 Function , 2012, International journal of molecular sciences.

[31]  Thelma Thompson,et al.  Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization , 2012, Proceedings of the National Academy of Sciences.

[32]  Alexander Dömling,et al.  The p53-MDM2/MDMX axis - A chemotype perspective. , 2011, MedChemComm.

[33]  J. Marine,et al.  Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.

[34]  K. Sakamaki,et al.  Caspases: evolutionary aspects of their functions in vertebrates , 2009, Journal of fish biology.

[35]  J. Bargonetti,et al.  Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D , 2006, Oncogene.

[36]  Keisuke Kuida,et al.  Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis , 2006, Science.

[37]  T. Wilczok,et al.  Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis. , 2005, Biochimica et biophysica acta.

[38]  J. Eberle,et al.  The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. , 2001, The Journal of investigative dermatology.

[39]  S. Haldar,et al.  The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. , 1998, Molecular human reproduction.

[40]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[41]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[42]  G. Lozano,et al.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.

[43]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.